XML 54 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 0 Months Ended
Dec. 31, 2011
year
Dec. 31, 2010
year
Dec. 31, 2009
year
Dec. 31, 2011
Restricted Stock [Member]
Dec. 31, 2010
Restricted Stock [Member]
Dec. 31, 2009
Restricted Stock [Member]
Dec. 31, 2011
Stock Options [Member]
Dec. 31, 2010
Stock Options [Member]
Dec. 31, 2009
Stock Options [Member]
Jan. 03, 2012
Stock Award [Member]
Feb. 09, 2012
Stock Award [Member]
Restricted Stock [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]                      
Share-based compensation incurred $ 8,247 $ 6,487 $ 7,139 $ 7,308 $ 5,232 $ 5,718 $ 939 $ 1,255 $ 1,421    
Capitalized share-based compensation (663) (745) (945)                
Share-based compensation expense 7,584 5,742 6,194                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]                      
Volatility   30.00% 28.60%                
Expected dividend yield   4.00% 3.60%                
Expected term (in years)   4.3 4.9                
Risk free interest rate   1.90% 1.60%                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]                      
Outstanding at the beginning of year (in shares) 757,424                    
Outstanding at the beginning of year, Weighted-Average Exercise Price (in dollars per share) $ 62.09                    
Granted (in shares) 0                    
Granted, Weighted-Average Exercise Price (in dollars per share) $ 0.00                    
Exercised (in shares) (237,271)                    
Exercised, Weighted-Average Exercise Price (in dollars per share) $ 64.02                    
Forfeited or expired (in shares) (2,500)                    
Forfeited or Expired, Weighted-Average Exercise Price (in dollars per share) $ 88.60                    
Outstanding at the end of year (in shares) 517,653 757,424                  
Outstanding at the end of year, Weighted-Average Exercise Price (in dollars per share) $ 61.08 $ 62.09                  
Outstanding at the end of year, Weighted-Average Remaining Contractual Term (in years) 5.9                    
Outstanding at the end of year, Intrinsic Value 15,423                    
Exercisable at the end of year (in shares) 286,054                    
Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 64.49                    
Exercisable, Weighted-Average Remaining Contractual Term (in years) 5.2                    
Exercisable, Aggregate Intrinsic Value $ 7,562                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]                      
Unvested at the beginning of year (in shares) 270,793                    
Unvested at the beginning of year, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 68.07                    
Granted (in shares) 103,383                 6,613 112,043
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 81.94 $ 73.51 $ 45.77                
Vested (in shares) (77,364)                    
Vested, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 68.51                    
Forfeited (in shares) (13,975)                    
Forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 48.30                    
Unvested at the end of year (in shares) 282,837 270,793                  
Unvested at the end of year, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 74.00 $ 68.07